Cytori Therapeutics Demonstrates Adipose Stem and Regenerative Cells Reduce Incidence of Arrhythmia after Heart Attacks in Preclinical Study

Source: Business Wire
Posted: April 21, 2006

SAN DIEGO--(BUSINESS WIRE)--April 21, 2006--Cytori Therapeutics, Inc. (NASDAQ:CYTX) (Frankfurt:XMPA) announced today preclinical data demonstrating that adipose stem and regenerative cell-based therapy following a heart attack in pigs is not associated with an increased risk of irregular heart rhythms, which can result in potentially life threatening complications from heart attacks.

Commentary: Hopefully clinical trials using adipose tissue to treat heart attacks will be successful in humans.